88
88163VAE9
Teva Pharmaceutical Industries Ltd
Could not find a ticker for this position, may be a filing error
A maker of generic and specialty medicines, Teva is one of the world's largest pharmaceutical companies, producing affordable versions of everyday drugs alongside branded treatments for conditions like multiple sclerosis. It began in 1901 as a small Jerusalem drug wholesaler called Salomon, Levin and Elstein that once delivered medicines by mule and camel caravan. The name "Teva" is Hebrew for "nature," chosen as the firm shifted from distributing to manufacturing medicine.
CONVERTIBLECUSIP: 88163VAE9HealthcareIL1 derivative reporter
0.25% convertible senior debentures due February 1, 2026
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
